ArticleFrontiers in oncology2025

Negative outcomes associated with tyrosine kinase inhibitors during management of gastrointestinal stromal tumors: examination of data from the FDA adverse event reporting system.

Yuxuan Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.